|
1
|
Guarner F and Malagelada JR: Gut flora in
health and disease. Lancet. 361:512–519. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ussar S, Griffin NW, Bezy O, Fujisaka S,
Vienberg S, Softic S, Deng L, Bry L, Gordon JI and Kahn CR:
Interactions between gut microbiota, host genetics and diet
modulate the predisposition to obesity and metabolic syndrome. Cell
Metab. 22:516–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abraham C and Cho JH: Inflammatory bowel
disease. N Engl J Med. 361:2066–2078. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scaldaferri F, Gerardi V, Lopetuso LR, Del
Zompo F, Mangiola F, Boškoski I, Bruno G, Petito V, Laterza L,
Cammarota G, et al: Gut microbial flora, prebiotics, and probiotics
in IBD: Their current usage and utility. Biomed Res Int.
2013:4352682013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hansen JJ: Immune responses to intestinal
microbes in inflammatory bowel diseases. Curr Allergy Asthma Rep.
15:612015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rup L: The human microbiome project.
Indian J Microbiol. 52:3152012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gevers D, Knight R, Petrosino JF, Huang K,
McGuire AL, Birren BW, Nelson KE, White O, Methé BA and Huttenhower
C: The human microbiome project: A community resource for the
healthy human microbiome. PLoS Biol. 10:e10013772012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ott SJ, Musfeldt M, Wenderoth DF, Hampe J,
Brant O, Fölsch UR, Timmis KN and Schreiber S: Reduction in
diversity of the colonic mucosa associated bacterial microflora in
patients with active inflammatory bowel disease. Gut. 53:685–693.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Morgan XC, Tickle TL, Sokol H, Gevers D,
Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, et
al: Dysfunction of the intestinal microbiome in inflammatory bowel
disease and treatment. Genome Biol. 13:R792012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sokol H, Lay C, Seksik P and Tannock GW:
Analysis of bacterial bowel communities of IBD patients: What has
it revealed? Inflamm Bowel Dis. 14:858–867. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Swidsinski A, Ladhoff A, Pernthaler A,
Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U,
Schreiber S, Dietel M and Lochs H: Mucosal flora in inflammatory
bowel disease. Gastroenterology. 122:44–54. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Petschow B, Doré J, Hibberd P, Dinan T,
Reid G, Blaser M, Cani PD, Degnan FH, Foster J, Gibson G, et al:
Probiotics, prebiotics, and the host microbiome: The science of
translation. Ann N Y Acad Sci. 1306:1–17. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rembacken BJ, Snelling AM, Hawkey PM,
Chalmers DM and Axon AT: Non-pathogenic Escherichia coli versus
mesalazine for the treatment of ulcerative colitis: A randomised
trial. Lancet. 354:635–639. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Prantera C and Scribano ML: Probiotics and
Crohn's disease. Dig Liver Dis. 34 Suppl 2:S66–S67. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hedin C, Whelan K and Lindsay JO: Evidence
for the use of probiotics and prebiotics in inflammatory bowel
disease: A review of clinical trials. Proc Nutr Soc. 66:307–315.
2007; View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gibson GR: Dietary modulation of the human
gut microflora using the prebiotics oligofructose and inulin. J
Nutr. 129 7 Suppl:1438S–1441S. 1999.PubMed/NCBI
|
|
17
|
Sartor RB: Therapeutic manipulation of the
enteric microflora in inflammatory bowel diseases: Antibiotics,
probiotics, and prebiotics. Gastroenterology. 126:1620–1633. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Everard A, Lazarevic V, Gaïa N, Johansson
M, Ståhlman M, Backhed F, Delzenne NM, Schrenzel J, François P and
Cani PD: Microbiome of prebiotic-treated mice reveals novel targets
involved in host response during obesity. ISME J. 8:2116–2130.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xia Y, Chen HQ, Zhang M, Jiang YQ, Hang XM
and Qin HL: Effect of Lactobacillus plantarum LP-Onlly on gut flora
and colitis in interleukin-10 knockout mice. J Gastroenterol
Hepatol. 26:405–411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Human Microbiome Project Consortium: A
framework for human microbiome research. Nature. 486:215–221. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Human Microbiome Project Consortium:
Structure, function and diversity of the healthy human microbiome.
Nature. 486:207–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zerbino DR and Birney E: Velvet:
Algorithms for de novo short read assembly using de Bruijn graphs.
Genome Res. 18:821–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu W, Lomsadze A and Borodovsky M: Ab
initio gene identification in metagenomic sequences. Nucleic Acids
Res. 38:e1322010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huerta-Cepas J, Szklarczyk D, Forslund K,
Cook H, Heller D, Walter MC, Rattei T, Mende DR, Sunagawa S, Kuhn
M, et al: eggNOG 4.5: A hierarchical orthology framework with
improved functional annotations for eukaryotic, prokaryotic and
viral sequences. Nucleic Acids Res. 44:D286–D293. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Edgar RC: MUSCLE: Multiple sequence
alignment with high accuracy and high throughput. Nucleic Acids
Res. 32:1792–1797. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sinha S and Lynn AM: HMM-ModE:
Implementation, benchmarking and validation with HMMER3. BMC Res
Notes. 7:4832014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dray S and Dufour AB: The ade4 package:
Implementing the duality diagram for ecologists. J Stat Softw.
22:202007. View Article : Google Scholar
|
|
28
|
Wixon J and Kell D: The Kyoto encyclopedia
of genes and genomes-KEGG. Yeast. 17:48–55. 2000.PubMed/NCBI
|
|
29
|
Markowitz VM: Microbial genome data
resources. Curr Opin Biotechnol. 18:267–272. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ganesh BP, Klopfleisch R, Loh G and Blaut
M: Commensal Akkermansia muciniphila exacerbates gut inflammation
in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One.
8:e749632013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kverka M, Zakostelska Z, Klimesova K,
Sokol D, Hudcovic T, Hrncir T, Rossmann P, Mrazek J, Kopecny J,
Verdu EF and Tlaskalova-Hogenova H: Oral administration of
Parabacteroides distasonis antigens attenuates experimental murine
colitis through modulation of immunity and microbiota composition.
Clin Exp Immunol. 163:250–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qin J, Li R, Raes J, Arumugam M, Burgdorf
KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al: A
human gut microbial gene catalogue established by metagenomic
sequencing. Nature. 464:59–65. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fenner L, Roux V, Mallet MN and Raoult D:
Bacteroides massiliensis sp. nov., isolated from blood culture of a
newborn. Int J Syst Evol Microbiol. 55:1335–1337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Png CW, Linden SK, Gilshenan KS, Zoetendal
EG, McSweeney CS, Sly LI, McGuckin MA and Florin TH: Mucolytic
bacteria with increased prevalence in IBD mucosa augment in vitro
utilization of mucin by other bacteria. Am J Gastroenterol.
105:2420–2428. 2010. View Article : Google Scholar : PubMed/NCBI
|
